What are you looking for?
For example, reimbursement, cannabis or side effects
Strategy for the DKMA
The Danish Medicines Agency has formulated a strategy for 2022-26. The strategy emphasizes a vision of leading the way in national and international cooperation, and in the dialogue with citizens and society. Read more.Go to theme
Here you can read about reimbursement, drugs affecting the ability to drive and other topics relevant for the general public.
Information on licensing, inspections, fees, company authorisations, clinical trials and more.
Henvendelser til Lægemiddelstyrelsen om status på indsendte ansøgninger for lægemidler godkendt via DCP, MRP eller national procedure
26 May 2023
The Danish Medicines Agency suspends the Danish marketing authorisations of four generic medicines
13 December 2022